Summary
The Conversion of OH-B12 to Ado-B12 probably involves two reductases and an adenosyltransferase (1, 2) . The enzymatic activity of the Ado-B12 synthesis has been reported to occur in bacterial (3) and animal cells (4) . Several studies (3, 4) have suggested that OH-B12 is a better substrate for the Ado-B12 synthesis than CN-B12. Conversion of CN-B12 to OH-B12 is probably the rate limiting step in synthesis of the coenzyme form. However, detailed enzymological information on the enzyme involved in decyanation of CN-B12 is not yet available.
Euglena gracilis has well-developed organelles like those of higher animals, and requires B12 for growth (5) ; it gives readily B12-limited cells (6) . Therefore, in regard to the elucidation of physiological function of B12 and the mechanism of the coenzyme form synthesis, E. gracilis is an organism suitable as a model of higher animal systems. a Specific activity (pmol/min/mg protein) given in parenth eses. b Specific activity (nmol/min/mg protein) given in parentheses. the fact that FAD and NADPH cannot pass inner membrane of mitochondria suggest that the enzyme is located in either the outside of inner membrane or outer membrane of Euglena mitochondria. A mechanism of the decyanation of CN-B12 by the enzyme is suggested from the cofactor requirement as follows: in a catalytic site of the enzyme, FAD (FMN) accepts two hydrogen atoms from NADPH to produce the reduced flavine nucleotide, which reduces CN-B12 to B12r or B12s. Subsequent hydroxylation is accomplished by reoxidation of the reduced B12. However, there is no enzymologi cal information available on the reoxidation reaction. Although occurrence of B12 r or B12s as an intermediate of the enzymatic decyanation of CN-B12 cannot be confirmed by spectral experiments because of the low activity , non-reductive conversion of CN-B12 to OH-B12 does not proceed chemically. Accordingly , the enzyme would be designated as CN-B12 reductase (NADPH; CN-eliminating) [EC 1.6.99.-].
We have reported the occurrence and characterization of aquacobalamin reductase (NADPH) [EC 1.6.99.-] involved in conversion of OH-B12 to B12 r in E.
gracilis (15, 16) . The Euglena aquacobalamin reductase, which was located in the soluble fraction of the mitochondria, did not require FAD or FMN as a cofactor , and was specific to NADPH and OH-B12; CN-B12 was not reduced to B12 r by the enzyme. Thus, the properties and subcellular location of the aquacobalamin reductase were quite different from those of the decyanating enzyme.
A proposed mechanism of Ado-B12 formation in E. gracilis is described below. CN-B12 taken up by Euglena cell is converted to OH-B12 in the mitochondria , probably in the outside of inner membrane or outer membrane, by the CN-B12 reductase. The CN-group released from CN-B12 would enter a cyanide detoxication system which involved rhodanese located in the Euglena cytosol (17) , while the formed OH-B12, after transferred to the mitochondrial matrix, is converted to Ado B12 by the actions of the three enzymes, aquacobalamin reductase, B12r reductase, and Bits adenosyltransferase. The synthesized Ado-B12 functions as a cofactor in methylmalonyl-CoA mutase and ribonucleotide reductase (18, 19) .
